PRMT5 regulates alternative splicing of TCF3 under hypoxia to promote EMT and invasion in breast cancer
PLOS Biology · 2025
DOI: 10.1371/journal.pbio.3003444 ↗At a glance
Journal article in PLOS Biology, 2025. Written by Srinivas Abhishek Mutnuru and 7 co-authors. Institution: Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, Madhya Pradesh, India. Major MEDLINE topics: Protein-Arginine N-Methyltransferases, Alternative Splicing, Breast Neoplasms, Epithelial-Mesenchymal Transition. Cited 7 times so far (Crossref); 94 references. The full text is freely available (open access, CC BY 4.0). Funded by: Indian Institute of Science Education and Research-Bhopal, India, Council of Scientific and Industrial Research fellowship, India, Department of Biotechnology (DBT, India).
Abstract (original language)
Tumor hypoxia induced alterations in the epigenetic landscape and alternative splicing influence cellular adaptations. PRMT5 is a type II protein arginine methyltransferase that regulates several tumorigenic events in many cancer types. However, the regulation of PRMT5 and its direct implication on aberrant alternative splicing under hypoxia remains unexplored. In this study, we observed hypoxia-induced upregulation of PRMT5 via the CTCF in human breast cancer cells. Further, PRMT5-mediated symmetric arginine dimethylation H4R3me2s and H3R8me2s directly regulated the alternative splicing of TCF3 . Under hypoxia, PRMT5-mediated histone dimethylation at the intronic conserved region (ICR) present between TCF3 exon 18a and exon 18b recruits DNMT3A, resulting in DNA methylation. DNA methylation at the TCF3 -ICR is recognized and bound by MeCP2 resulting in RNA-Pol II pausing, promoting the recruitment of the negative splicing factor PTBP1 to the splicing locus of TCF3 pre-mRNA. PTBP1 promotes the exclusion of exon 18a which results in the production of the pro-invasive TCF3-18B (E47) isoform which promotes EMT and invasion of breast cancer cells under hypoxia. Collectively, our results indicate PRMT5-mediated symmetric arginine dimethylation of histones regulates alternative splicing of TCF3 gene thereby enhancing EMT and invasion in breast cancer hypoxia.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, Madhya Pradesh, India.
- Department of Pathology, Bansal Hospital, Bhopal, Madhya Pradesh, India.
- Department of Surgical Oncology, Bansal Hospital, Bhopal, Madhya Pradesh, India.
ORCID profiles: Sanjeev Shukla
Funding
- Indian Institute of Science Education and Research-Bhopal, India
- Council of Scientific and Industrial Research fellowship, India
- Department of Biotechnology (DBT, India)
- Indian Institute of Science Education and Research
- Council of Scientific and Industrial Research
- Beth Israel Deaconess Medical Center
- Department of Biotechnology India
- Science and Engineering Research Board
Cite
APA
Mutnuru, S. A., Yadav, P., Kakani, P., Dhamdhere, S. G., Kumari, P., Agrawal, S., Samaiya, A., & Shukla, S. (2025). PRMT5 regulates alternative splicing of TCF3 under hypoxia to promote EMT and invasion in breast cancer. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003444
Vancouver
Mutnuru SA, Yadav P, Kakani P, Dhamdhere SG, Kumari P, Agrawal S, et al. PRMT5 regulates alternative splicing of TCF3 under hypoxia to promote EMT and invasion in breast cancer. PLOS Biology. 2025. doi:10.1371/journal.pbio.3003444
BibTeX
@article{Mutnuru2025,
author = {Mutnuru, Srinivas Abhishek and Yadav, Pooja and Kakani, Parik and Dhamdhere, Shruti Ganesh and Kumari, Poorva and Agrawal, Shruti and Samaiya, Atul and Shukla, Sanjeev},
title = {PRMT5 regulates alternative splicing of TCF3 under hypoxia to promote EMT and invasion in breast cancer},
journal = {PLOS Biology},
year = {2025},
doi = {10.1371/journal.pbio.3003444}
}
EUVIMED